{"id":53046,"date":"2023-01-18T17:03:45","date_gmt":"2023-01-18T16:03:45","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/viecure-aligns-with-oncology-care-partners-to-accelerate-the-adoption-of-value-based-cancer-care\/"},"modified":"2023-01-18T17:03:45","modified_gmt":"2023-01-18T16:03:45","slug":"viecure-aligns-with-oncology-care-partners-to-accelerate-the-adoption-of-value-based-cancer-care","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/viecure-aligns-with-oncology-care-partners-to-accelerate-the-adoption-of-value-based-cancer-care\/","title":{"rendered":"VieCure Aligns with Oncology Care Partners to Accelerate the Adoption of Value-Based Cancer Care"},"content":{"rendered":"
\n

\nOncology Care Partners selects the VieCure\u2122 Halo Intelligence platform to provide the best patient experience in cancer care\n<\/p>\n

DENVER & NASHVILLE, Tenn.–(BUSINESS WIRE)–VieCure today announced a new strategic partnership with value-based care organization, Oncology Care Partners (\u201cOCP\u201d), which will assist OCP in its provision of world-class care to patients across its growing U.S. network. This collaboration will support OCP\u2019s providers in creating personalized treatment plans using VieCure\u2019s Halo Intelligence Platform and help OCP to advance its commitment to overall health equity for the patients that they serve. This partnership will be impactful as both companies are dedicated to revolutionizing the way that cancer patients are treated. OCP is committed to a new generation of cancer care, ensuring that patients are treated with \u201cwhole-person care,\u201d giving them the opportunity to ensure the patient and family will be supported and engaged throughout the entire care process. Currently, OCP has opened its initial practice in Phoenix, Arizona, and is caring for Medicare Advantage patients in the surrounding area. It has also recently acquired an existing practice in Miami, where it will bring its value-based care model to patients in South Florida. OCP is in the process of expanding to deliver world-class, community-based care throughout the country while striving for more efficient and individualized treatment options, and VieCure is proud to power all practices in its growing network. OCP is working to reduce unnecessary services which can in turn lower costs and lower the burden placed on patients. Value-based care will ensure that patients receive the most comprehensive and efficient care, and in turn, improve the overall quality of life for patients and their families.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\n\u201cWe view VieCure as an important strategic partner, we share a mission: to make cancer care better for patients. As this partnership grows, we have the opportunity to accelerate growth for both companies and, by extension, the positive impact on cancer patients,\u201d said Joe Pietrzak, Oncology Care Partners CFO, and head of development.\n<\/p>\n

\nVieCure has developed a proprietary artificial intelligence informatics software platform and combined it with a clinical inference engine, a codified content library, a patient mobile app, a physician mobile app, integrated Tele oncology, and a fulsome data and analytics solution. This comprehensive suite, all tethered to the A.I. clinical inference engine, is the market-leading point-of-care clinical decision support system in oncology. VieCure will also codify the New Century Pathways in algorithms for use by clinicians at OCP practices.\n<\/p>\n

\n\u201cVieCure\u2019s AI-based decision support platform with its world-leading knowledge library, including standard of care and precision medicine, will enable OCP\u2019s clinicians to give their patients the most appropriate, cost-effective care tailored to their unique circumstances,\u201d said Dr. Fred Ashbury, VieCure\u2019s Chief Scientific Officer.\n<\/p>\n

\nAbout VieCure<\/b>\n<\/p>\n

\nVieCure has developed a proprietary artificial intelligence informatics software platform in conjunction with a clinical inference engine and point-of-care decision support system in oncology. The VieCure\u2122 platform combines the latest in clinical knowledge with patient data to assist clinicians in generating personalized treatment plans and better managing a patient\u2019s treatment throughout diagnosis, cancer therapy, and ongoing follow-up care. VieCure was launched in 2015 and has contracted with leading community oncology cancer centers like the Center for Cancer and Blood Disorders (Fort Worth, Texas), Alabama Cancer Care (Tuscaloosa, Alabama), Clermont Oncology (Clermont, Florida), and several others including the American Oncology Network. The VieCure contracted cancer center network now includes more than 100 locations in the United States, the Bahamas, and Antigua. Active implementation of the VieCure platform is occurring in network locations across the United States. For more information, please visit viecure.com and connect with VieCure on LinkedIn, Facebook, and YouTube.\n<\/p>\n

\nAbout Oncology Care Partners<\/b>\n<\/p>\n

\nOncology Care Partners (OCP) is an oncology provider built solely to provide value-based care serving Medicare Advantage patients. OCP\u2019s community-based physicians serve every patient with high-touch, whole-person care that includes more time with a doctor, a dedicated advocate, clear and open communication, and 24\/7 connectivity. OCP was launched by Valtruis<\/a>, a WCAS<\/a> company that provides a unique platform to transform healthcare through what is truly value-based care, and partners with New Century Health<\/a>, a national pioneer in oncology and cardiology care management. OCP\u2019s innovative model of care reduces unnecessary services, lowers costs, and adds value for patients, doctors, and providers. For more information, visit OncologyCarePartners.com.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nFor More Information, Contact:<\/b>
VieCure, Inc.
\n
Hailey Hogue, Coordinator, Marketing and Social Media
\n
hailey.hogue@viecure.com<\/a>\n<\/p>\n

\nOncology Care Partners
\n
Andrew King, Public Relations
\n
aking@getinvolve.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Oncology Care Partners selects the VieCure\u2122 Halo Intelligence platform to provide the best patient experience in cancer care DENVER & NASHVILLE, Tenn.–(BUSINESS WIRE)–VieCure today announced a new strategic partnership with value-based care organization, Oncology Care Partners (\u201cOCP\u201d), which will assist OCP in its provision of world-class care to patients across its growing U.S. network. This … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53046","6":"format-standard","7":"category-industry"},"yoast_head":"\nVieCure Aligns with Oncology Care Partners to Accelerate the Adoption of Value-Based Cancer Care - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/viecure-aligns-with-oncology-care-partners-to-accelerate-the-adoption-of-value-based-cancer-care\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"VieCure Aligns with Oncology Care Partners to Accelerate the Adoption of Value-Based Cancer Care - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Oncology Care Partners selects the VieCure\u2122 Halo Intelligence platform to provide the best patient experience in cancer care DENVER & NASHVILLE, Tenn.–(BUSINESS WIRE)–VieCure today announced a new strategic partnership with value-based care organization, Oncology Care Partners (\u201cOCP\u201d), which will assist OCP in its provision of world-class care to patients across its growing U.S. network. This ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/viecure-aligns-with-oncology-care-partners-to-accelerate-the-adoption-of-value-based-cancer-care\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-18T16:03:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230118005642\/en\/1689257\/21\/Screen_Shot_2023-01-18_at_9.02.40_AM.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viecure-aligns-with-oncology-care-partners-to-accelerate-the-adoption-of-value-based-cancer-care\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viecure-aligns-with-oncology-care-partners-to-accelerate-the-adoption-of-value-based-cancer-care\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"VieCure Aligns with Oncology Care Partners to Accelerate the Adoption of Value-Based Cancer Care\",\"datePublished\":\"2023-01-18T16:03:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viecure-aligns-with-oncology-care-partners-to-accelerate-the-adoption-of-value-based-cancer-care\\\/\"},\"wordCount\":760,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viecure-aligns-with-oncology-care-partners-to-accelerate-the-adoption-of-value-based-cancer-care\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230118005642\\\/en\\\/1689257\\\/21\\\/Screen_Shot_2023-01-18_at_9.02.40_AM.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viecure-aligns-with-oncology-care-partners-to-accelerate-the-adoption-of-value-based-cancer-care\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viecure-aligns-with-oncology-care-partners-to-accelerate-the-adoption-of-value-based-cancer-care\\\/\",\"name\":\"VieCure Aligns with Oncology Care Partners to Accelerate the Adoption of Value-Based Cancer Care - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viecure-aligns-with-oncology-care-partners-to-accelerate-the-adoption-of-value-based-cancer-care\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viecure-aligns-with-oncology-care-partners-to-accelerate-the-adoption-of-value-based-cancer-care\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230118005642\\\/en\\\/1689257\\\/21\\\/Screen_Shot_2023-01-18_at_9.02.40_AM.jpg\",\"datePublished\":\"2023-01-18T16:03:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viecure-aligns-with-oncology-care-partners-to-accelerate-the-adoption-of-value-based-cancer-care\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viecure-aligns-with-oncology-care-partners-to-accelerate-the-adoption-of-value-based-cancer-care\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viecure-aligns-with-oncology-care-partners-to-accelerate-the-adoption-of-value-based-cancer-care\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230118005642\\\/en\\\/1689257\\\/21\\\/Screen_Shot_2023-01-18_at_9.02.40_AM.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230118005642\\\/en\\\/1689257\\\/21\\\/Screen_Shot_2023-01-18_at_9.02.40_AM.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viecure-aligns-with-oncology-care-partners-to-accelerate-the-adoption-of-value-based-cancer-care\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"VieCure Aligns with Oncology Care Partners to Accelerate the Adoption of Value-Based Cancer Care\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"VieCure Aligns with Oncology Care Partners to Accelerate the Adoption of Value-Based Cancer Care - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/viecure-aligns-with-oncology-care-partners-to-accelerate-the-adoption-of-value-based-cancer-care\/","og_locale":"en_US","og_type":"article","og_title":"VieCure Aligns with Oncology Care Partners to Accelerate the Adoption of Value-Based Cancer Care - Pharma Trend","og_description":"Oncology Care Partners selects the VieCure\u2122 Halo Intelligence platform to provide the best patient experience in cancer care DENVER & NASHVILLE, Tenn.–(BUSINESS WIRE)–VieCure today announced a new strategic partnership with value-based care organization, Oncology Care Partners (\u201cOCP\u201d), which will assist OCP in its provision of world-class care to patients across its growing U.S. network. This ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/viecure-aligns-with-oncology-care-partners-to-accelerate-the-adoption-of-value-based-cancer-care\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-18T16:03:45+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230118005642\/en\/1689257\/21\/Screen_Shot_2023-01-18_at_9.02.40_AM.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/viecure-aligns-with-oncology-care-partners-to-accelerate-the-adoption-of-value-based-cancer-care\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/viecure-aligns-with-oncology-care-partners-to-accelerate-the-adoption-of-value-based-cancer-care\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"VieCure Aligns with Oncology Care Partners to Accelerate the Adoption of Value-Based Cancer Care","datePublished":"2023-01-18T16:03:45+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/viecure-aligns-with-oncology-care-partners-to-accelerate-the-adoption-of-value-based-cancer-care\/"},"wordCount":760,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/viecure-aligns-with-oncology-care-partners-to-accelerate-the-adoption-of-value-based-cancer-care\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230118005642\/en\/1689257\/21\/Screen_Shot_2023-01-18_at_9.02.40_AM.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/viecure-aligns-with-oncology-care-partners-to-accelerate-the-adoption-of-value-based-cancer-care\/","url":"https:\/\/pharma-trend.com\/en\/viecure-aligns-with-oncology-care-partners-to-accelerate-the-adoption-of-value-based-cancer-care\/","name":"VieCure Aligns with Oncology Care Partners to Accelerate the Adoption of Value-Based Cancer Care - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/viecure-aligns-with-oncology-care-partners-to-accelerate-the-adoption-of-value-based-cancer-care\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/viecure-aligns-with-oncology-care-partners-to-accelerate-the-adoption-of-value-based-cancer-care\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230118005642\/en\/1689257\/21\/Screen_Shot_2023-01-18_at_9.02.40_AM.jpg","datePublished":"2023-01-18T16:03:45+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/viecure-aligns-with-oncology-care-partners-to-accelerate-the-adoption-of-value-based-cancer-care\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/viecure-aligns-with-oncology-care-partners-to-accelerate-the-adoption-of-value-based-cancer-care\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/viecure-aligns-with-oncology-care-partners-to-accelerate-the-adoption-of-value-based-cancer-care\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230118005642\/en\/1689257\/21\/Screen_Shot_2023-01-18_at_9.02.40_AM.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230118005642\/en\/1689257\/21\/Screen_Shot_2023-01-18_at_9.02.40_AM.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/viecure-aligns-with-oncology-care-partners-to-accelerate-the-adoption-of-value-based-cancer-care\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"VieCure Aligns with Oncology Care Partners to Accelerate the Adoption of Value-Based Cancer Care"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53046","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53046"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53046\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53046"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53046"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53046"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}